Table 3 Exemplary characterization of two maxima of peaks in both lung and throat samples
| Â | Site | SARS-CoV-2 PCR negative | SARS-CoV-2 PCR positive | AROC (CI) | pU (result) | ||
|---|---|---|---|---|---|---|---|
Mean (SD) | Median (Q1 … Q3) | Mean (SD) | Median (Q1 … Q3) | ||||
Peak 1-lung
| TUM | 17.57 (11.46) | 14.72 (10.11 … 21.31) | 13.21 (8.73) | 11.59 (8.13 … 15.20) | 0.357 (0.296 … 0.418) | < 0.001 |
CBF | 17.32 (8.08) | 16.14 (11.48 … 21.80) | 12.56 (4.94) | 10.65 (8.43 … 16.98) | 0.306 (0.183 … 0.428) | 0.005 | |
pU (site) | 0.521 | 0.728 | Â | Â | |||
Peak 1-throat
| TUM | 18.04 (11.32) | 14.55 (11.12 … 21.07) | 14.08 (9.88) | 11.42 (8.55 … 15.07) | 0.346 (0.285 … 0.407) | < 0.001 |
CBF | 19.10 (10.96) | 15.97 (11.74 … 21.65) | 13.66 (6.51) | 13.50 (8.70 … 15.22) | 0.323 (0.198 … 0.447) | 0.010 | |
pU (site) | 0.371 | 0.365 | Â | Â | |||
Peak 2-lung
| TUM | 9.75 (9.41) | 8.70 (6.30 … 11.01) | 8.66 (9.25) | 7.14 (5.48 … 9.24) | 0.374 (0.312 … 0.436) | < 0.001 |
CBF | 6.85 (3.83) | 5.83 (4.75 … 7.62) | 5.31 (2.10) | 4.67 (4.02 … 6.56) | 0.335 (0.207 … 0.462) | 0.017 | |
pU (site) | < 0.001 | < 0.001 |  |  | |||
Peak 2-throat
| TUM | 16.23 (19.42) | 12.82 (8.97 … 19.09) | 12.15 (9.43) | 9.88 (7.12 … 14.92) | 0.381 (0.318 … 0.443) | < 0.001 |
CBF | 7.40 (3.77) | 6.29 (5.09 … 8.29) | 5.85 (1.69) | 5.76 (4.47 … 6.84) | 0.379 (0.248 … 0.509) | 0.080 | |
pU (site) | < 0.001 | < 0.001 |  |  | |||
